CD47 and cancer: The cancer cells cultured with MSCHigh expressed significantly lower levels of CD47 than those cultured with the monocytic cell line (Figure 7B), reinforcing the hypothesis that stromal cells can act on the cancer cells to alter the function and phenotype.